TSE:COM

138267 (COM.TO) Competitors

Add
Compare
Today's Range N/A
50-Day Range
C$2.95
MA: C$2.95
C$2.95
52-Week Range N/A
Volume9,197 shs
Average Volume19,585 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

138267 (COM.TO) (TSE:COM) Vs. CHV, PREV, MYM, CURE, HALO, and LTY

Should you be buying COM stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to 138267 (COM.TO), including (CHV) (CHV), (PREV) (PREV), 17031 (MYM), Direxion Daily Healthcare Bull 3X Shares (CURE), Halozyme Therapeutics (HALO), and Liberty Biopharma (LTY).

138267 (COM.TO) (TSE:COM) and (CHV) (CNSX:CHV) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares 138267 (COM.TO) and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
(CHV)N/AN/AN/A

Valuation and Earnings

This table compares 138267 (COM.TO) and (CHV)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
(CHV)N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for 138267 (COM.TO) and (CHV), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
(CHV)0000N/A

138267 (COM.TO) (TSE:COM) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Profitability

This table compares 138267 (COM.TO) and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
(PREV)N/AN/AN/A

Earnings & Valuation

This table compares 138267 (COM.TO) and (PREV)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
(PREV)N/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for 138267 (COM.TO) and (PREV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
(PREV)0000N/A

138267 (COM.TO) (TSE:COM) and 17031 (CNSX:MYM) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

Profitability

This table compares 138267 (COM.TO) and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
17031N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for 138267 (COM.TO) and 17031, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
170310000N/A

Earnings & Valuation

This table compares 138267 (COM.TO) and 17031's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
17031N/AN/AN/AN/AN/A

Direxion Daily Healthcare Bull 3X Shares (CNSX:CURE) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership and dividends.

Valuation and Earnings

This table compares Direxion Daily Healthcare Bull 3X Shares and 138267 (COM.TO)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/AN/AN/A
138267 (COM.TO)N/AN/AN/AN/AN/A

Profitability

This table compares Direxion Daily Healthcare Bull 3X Shares and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Direxion Daily Healthcare Bull 3X Shares and 138267 (COM.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Direxion Daily Healthcare Bull 3X Shares0000N/A
138267 (COM.TO)0000N/A

Halozyme Therapeutics (NEO:HALO) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Earnings & Valuation

This table compares Halozyme Therapeutics and 138267 (COM.TO)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Halozyme TherapeuticsC$267.59 million24.79C$130.40 millionC$0.9150.88
138267 (COM.TO)N/AN/AN/AN/AN/A

Halozyme Therapeutics has higher revenue and earnings than 138267 (COM.TO).

Analyst Recommendations

This is a summary of recent ratings and price targets for Halozyme Therapeutics and 138267 (COM.TO), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Halozyme Therapeutics00014.00
138267 (COM.TO)0000N/A

Halozyme Therapeutics presently has a consensus target price of C$0.27, suggesting a potential downside of 99.42%.

Profitability

This table compares Halozyme Therapeutics and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Halozyme TherapeuticsN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Summary

Halozyme Therapeutics beats 138267 (COM.TO) on 2 of the 2 factors compared between the two stocks.

138267 (COM.TO) (TSE:COM) and Liberty Biopharma (CVE:LTY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and recommmendations for 138267 (COM.TO) and Liberty Biopharma, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
Liberty Biopharma0000N/A

Profitability

This table compares 138267 (COM.TO) and Liberty Biopharma's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
Liberty BiopharmaN/AN/AN/A

Earnings and Valuation

This table compares 138267 (COM.TO) and Liberty Biopharma's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66


138267 (COM.TO) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
HALO
Halozyme Therapeutics
1.3$46.30flatC$0.00C$267.59 million50.88News Coverage
LTY
Liberty Biopharma
0.6$2.00flatC$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
SCYB
Scythian Biosciences
0.5$3.49flatC$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32flatC$0.00N/A0.00Gap Down
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.